Table of Content




1. Introduction


2. Research Methodology

3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Allergic Conjunctivitis Market and Patients Analysis

5.1 Market
5.2 Patient Numbers
5.3 Treated Patient Numbers


6. Share Analysis – Global Allergic Conjunctivitis

6.1 Country Market Share
6.2 Patients Population Share
6.3 Treated Patients Population Share
6.4 By Disease Type Share


7. India – Allergic Conjunctivitis Analysis

7.1 Patient Numbers
7.2 Treated Patient Numbers
7.3 Market


8. China – Allergic Conjunctivitis Analysis

8.1 Patient Numbers
8.2 Treated Patient Numbers
8.3 Market


9. Japan – Allergic Conjunctivitis Analysis

9.1 Patient Numbers
9.2 Treated Patient Numbers
9.3 Market


10. United States – Allergic Conjunctivitis Analysis

10.1 Patient Numbers
10.2 Treated Patient Numbers
10.3 Market


11. United Kingdom – Allergic Conjunctivitis Analysis

11.1 Patient Number
11.2 Treated Patient Numbers
11.3 Market


12. France – Allergic Conjunctivitis Analysis

12.1 Patient Numbers
12.2 Treated Patient Numbers
12.3 Market


13. Germany – Allergic Conjunctivitis Analysis

13.1 Patient Numbers
13.2 Treated Patient Numbers
13.3 Market


14. Italy – Allergic Conjunctivitis Analysis

14.1 Patient Numbers
14.2 Treated Patient Numbers
14.3 Market


15. Spain – Allergic Conjunctivitis Analysis

15.1 Patient Numbers
15.2 Treated Patient Numbers
15.3 Market


16. Disease Type – Global Allergic Conjunctivitis Market

16.1 Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC)
16.2 Vernal Keratoconjunctivitis (VKC)
16.3 Atopic Keratoconjunctivitis (AKC)
16.4 Giant Papillary Conjunctivitis (GPC)


17. Global Allergic Conjunctivitis Pipeline Drugs

17.1 Zerviate
17.2 OTX-DP (Dexamethasone Insert)
17.3 ADX-102
17.4 PRT2761
17.5 CVXL-0074
17.6 AK-002
17.7 Bertilimumab
17.8 Reproxalap
17.9 ST-266
17.10 SYL-116011


18. Company Analysis

18.1 Santen Pharmaceutical

18.1.1 Company Overview
18.1.2 Recent Developments
18.1.3 Financial Insight

18.2 Alcon Inc. (Novartis)

18.2.1 Company Overview
18.2.2 Recent Developments
18.2.3 Financial Insight

18.3 Portola Pharmaceuticals Inc.

18.3.1 Company Overview
18.3.2 Recent Developments
18.3.3 Financial Insight

18.4 Ocular Therapeutix Inc.

18.4.1 Company Overview
18.4.2 Recent Developments
18.4.3 Financial Insight



List of Figures



Figure 2-1: Global - Allergic Conjunctivitis Market (Million US$), 2016 – 2020
Figure 2-2: Global – Forecast for Allergic Conjunctivitis Market (Million US$), 2021 – 2027
Figure 2-3: Global - Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2020
Figure 2-4: Global – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 – 2027
Figure 2-5: Global - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 – 2020
Figure 2-6: Global – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2021 – 2027
Figure 3-1: Global - Allergic Conjunctivitis Market Country Share (Percent), 2016 – 2020
Figure 3-2: Global – Forecast for Allergic Conjunctivitis Market Country Share (Percent), 2021 – 2027
Figure 3-3: Global - Allergic Conjunctivitis Treated Patients Population Country Share (Percent), 2016 – 2020
Figure 3-4: Global – Forecast for Allergic Conjunctivitis Treated Patients Population Country Share (Percent), 2021 – 2027
Figure 3-5: Global - Allergic Conjunctivitis Disease Type Market Share (Percent), 2016 – 2020
Figure 3-6: Global – Forecast for Allergic Conjunctivitis Disease Type Market Share (Percent), 2021 – 2027
Figure 4-1: India - Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2020
Figure 4-2: India – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 – 2027
Figure 4-3: India - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 – 2020
Figure 4-4: India – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2021 – 2027
Figure 4-5: India - Allergic Conjunctivitis Market (Million US$), 2016 – 2020
Figure 4-6: India – Forecast for Allergic Conjunctivitis Market (Million US$), 2021 – 2027
Figure 5-1: China - Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2020
Figure 5-2: China – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 – 2027
Figure 5-3: China - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 – 2020
Figure 5-4: China – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2021 – 2027
Figure 5-5: China - Allergic Conjunctivitis Market (Million US$), 2016 – 2020
Figure 5-6: China – Forecast for Allergic Conjunctivitis Market (Million US$), 2021 – 2027
Figure 6-1: Japan - Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2020
Figure 6-2: Japan – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 – 2027
Figure 6-3: Japan - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 – 2020
Figure 6-4: Japan – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 6-5: Japan - Allergic Conjunctivitis Market (Million US$), 2016 – 2020
Figure 6-6: Japan – Forecast for Allergic Conjunctivitis Market (Million US$), 2021 – 2027
Figure 7-1: United States - Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2020
Figure 7-2: United States – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 – 2027
Figure 7-3: United States - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 – 2020
Figure 7-4: United States – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2021 – 2027
Figure 7-5: United States – Allergic Conjunctivitis Market (Million US$), 2016 – 2020
Figure 7-6: United States – Forecast for Allergic Conjunctivitis Market (Million US$), 2021 – 2027
Figure 8-1: United Kingdom - Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2020
Figure 8-2: United Kingdom – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 – 2027
Figure 8-3: United Kingdom - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 – 2020
Figure 8-4: United Kingdom – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2021 – 2027
Figure 8-5: United Kingdom - Allergic Conjunctivitis Market (Million US$), 2016 – 2020
Figure 8-6: United Kingdom – Forecast for Allergic Conjunctivitis Market (Million US$), 2021 – 2027
Figure 9-1: France - Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2020
Figure 9-2: France – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 – 2027
Figure 9-3: France - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 – 2020
Figure 9-4: France – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2021 – 2027
Figure 9-5: France - Allergic Conjunctivitis Market (Million US$), 2016 – 2020
Figure 9-6: France – Forecast for Allergic Conjunctivitis Market (Million US$), 2021 – 2027
Figure 10-1: Germany - Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2020
Figure 10-2: Germany – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 – 2027
Figure 10-3: Germany - Allergic Conjunctivitis Patient Treated Numbers (Million), 2016 – 2020
Figure 10-4: Germany – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2021 – 2027
Figure 10-5: Germany - Allergic Conjunctivitis Market (Million US$), 2016 – 2020
Figure 10-6: Germany – Forecast for Allergic Conjunctivitis Market (Million US$), 2021 – 2027
Figure 11-1: Italy - Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2020
Figure 11-2: Italy – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 – 2027
Figure 11-3: Italy - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 – 2020
Figure 11-4: Italy – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2021 – 2027
Figure 11-5: Italy - Allergic Conjunctivitis Market (Million US$), 2016 – 2020
Figure 11-6: Italy – Forecast for Allergic Conjunctivitis Market (Million US$), 2021 – 2027
Figure 12-1: Spain - Allergic Conjunctivitis Patient Numbers (Million), 2016 – 2020
Figure 12-2: Spain – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 – 2027
Figure 12-3: Spain - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 – 2020
Figure 12-4: Spain – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2021 – 2027
Figure 12-5: Spain - Allergic Conjunctivitis Market (Million US$), 2016 – 2020
Figure 12-6: Spain – Forecast for Allergic Conjunctivitis Market (Million US$), 2021 – 2027
Figure 13-1: Global - Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Market (Million US$), 2016 – 2020
Figure 13-2: Global – Forecast for Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Market (Million US$), 2021 – 2027
Figure 13-3: Global - Vernal Keratoconjunctivitis (VKC) Market (Million US$), 2016 – 2020
Figure 13-4: Global – Forecast for Vernal Keratoconjunctivitis (VKC) Market (Million US$), 2021 – 2027
Figure 13-5: Global - Atopic Keratoconjunctivitis (AKC) Market (Million US$), 2016 – 2020
Figure 13-6: Global – Forecast for Atopic Keratoconjunctivitis (AKC) Market (Million US$), 2021 – 2027
Figure 13-7: Global - Giant Papillary Conjunctivitis (GPC) Market (Million US$), 2016 – 2020
Figure 13-8: Global – Forecast for Giant Papillary Conjunctivitis (GPC) Market (Million US$), 2021 – 2027
Figure 14-1: Allergic Conjunctivitis Pipe Line Drug – Zerviate Status (2018)
Figure 14-2: Allergic Conjunctivitis Pipe Line Drug – OTX-DP (Dexamethasone Insert) Status (2018)
Figure 14-3: Allergic Conjunctivitis Pipe Line Drug – ADX-102 Status (2018)
Figure 14-4: Allergic Conjunctivitis Pipe Line Drug – PRT-2761Status (2018)
Figure 14-5: Allergic Conjunctivitis Pipe Line Drug – CVXL-0074 Status (2018)
Figure 14-6: Allergic Conjunctivitis Pipe Line Drug – AK-002 Status (2018)
Figure 14-7: Allergic Conjunctivitis Pipe Line Drug – Bertilimumab Status (2018)
Figure 14-8: Allergic Conjunctivitis Pipe Line Drug – Reproxalap Status (2018)
Figure 14-9: Allergic Conjunctivitis Pipe Line Drug – ST-266 Status (2018)
Figure 14-10: Allergic Conjunctivitis Pipe Line Drug – SYL-116011 Status (2018)
Figure 17-1: Santen Pharmaceutical – Global Revenue (Million US$), 2016 - 2020
Figure 17-2: Santen Pharmaceutical – Forecast for Global Revenue (Million US$), 2021 - 2027
Figure 18-1: Alcon (Novartis) – Global Revenue (Million US$), 2016 - 2020
Figure 18-2: Alcon (Novartis) – Forecast for Global Revenue (Million US$), 2021 - 2027
Figure 19-1: Portola Pharmaceuticals – Global Revenue (Thousand US$), 2016 - 2020
Figure 19-2: Portola Pharmaceuticals – Forecast for Global Revenue (Thousand US$), 2021 - 2027
Figure 20-1: Ocular Therapeutix – Global Revenue (Thousand US$), 2016 - 2020
Figure 20-2: Ocular Therapeutix – Forecast for Global Revenue (Thousand US$), 2021 - 2027
Figure 21-1: Novartis – Global Revenue (Million US$), 2016 - 2020
Figure 21-2: Novartis – Forecast for Global Revenue (Thousand US$), 2021 - 2027


List of Tables



Table 3-1: Global - Allergic Conjunctivitis Patients Population Country Share (Percent), 2016 – 2020
Table 3-2: Global – Forecast for Allergic Conjunctivitis Patients Population Country Share (Percent), 2021 – 2027